ARCHIVES

Individualized Cancer Vaccines Show 90% Survival at 6 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

January 23, 1981

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

Small Businesses Receive $18 Million From NCI Through SBIR Program

July 31, 1992